Minerva Surgical raises $25M for device that reduces menstrual bleeding

Minerva Surgical, which is developing a device that treats abnormally heavy mentrual bleeding, said in a regulatory filing Monday that it has raised more than $25 million in new funding.

The Redwood City company led by President David Clapper didn't say who the funding came from but indicated that it was a round started on Sept. 12 and involves 26 investors.

 

Minerva's device, known as the Aurora Endometrial Ablation System, uses a balloon and an electrode array in a treatment that the company says takes four minutes. The condition it treats affects about one in five women, the company said, and the treatment is meant for women who don't want to have children afterwards.

MedRes Medical Research Engineering Ltd.

logo

Albert Flórián út 3/b, 1097 Budapest, Hungary
00 36 1 235 0306

Red MSZ EN ISO 13485

About MedRes

MedRes Medical Research Engineering Ltd. is a leading, tried and tested consultant and knowledge center that delivers prototyping solutions and clinical services for the development and commercialization of medical devices.

June 02, 2016
March 31, 2016

NOTE! This site uses cookies and similar technologies.

If you do not change browser settings, you agree to it. Learn more

I understand

© 2016 Medres LTD. All Rights Reserved. Designed By DesArt.hu